Contraceptive Technology and Reproductive Health Series: Home Page Contraceptive Technology and Reproductive Health Series Back to FHI Website
Injectable Contraceptives
Introduction Contents Post-Test References Go To Presenter Info

Goals

Section 1
Section 2
Section 3

- Activity
> NET-EN
- Objectives
- Similarities
- Differences
- Side Effects
- When to Begin
- Schedule

Section 4
Section 5

Conclusion

Previous pageNext page

Section 3 - Progestin-Only Injectables: NET-EN

NET-EN

NET-EN
  • Known as Noristerat or Norigest

  • 200 mg every 2 months

Slide 35


Next, we will discuss the characteristics of NET-EN, another progestin-only injectable contraceptive, known commercially as Noristerat or Norigest. Women using NET-EN receive a deep intramuscular injection once every two months at a dose of 200 milligrams.

NET-EN is less widely used and less widely studied than DMPA. However, its characteristics are very similar to those of DMPA. We will first summarize the ways in which NET-EN and DMPA are similar, and then describe the ways in which they differ.

 

Back

Previous page      Next page

Next